Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Madrigal Pharmaceuticals Inc
MDGLCurrent price
333.39 USD
+10.15 USD (+3.14%)
Last closed
323.24 USD
Company
www.madrigalpharma.com
ISIN
US5588681057
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
6 782 816 256 USD
Yield for 12 month
+40.83 %
1Y
3Y
5Y
10Y
15Y
MDGL
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania. Address: Four Tower Bridge, West Conshohocken, PA, United States, 19428
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
373.00 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
+62 175 000 USD
Last Quarter
+14 638 000 USD
Current Year
-527 000 USD
Last Year
-467 000 USD
Current Quarter
+60 023 000 USD
Last Quarter
+13 735 000 USD
Key Figures MDGL
1 year
3 years
5 years
10 years
EBITDA
-547 180 032 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-52.25 %
PEG Ratio
–
Return On Equity TTM
-129.76 %
Wall Street Target Price
373.00 USD
Revenue TTM
76 813 000 USD
Book Value
35.64 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-25.03 USD
Diluted Eps TTM
-25.03 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics MDGL
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History MDGL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:35
Payout Ratio
–
Last Split Date
25.07.2016
Dividend Date
25.07.2016
Stock Valuation MDGL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
76.85
Price Sales TTM
88.30
Enterprise Value EBITDA
-8.32
Price Book MRQ
8.73
Financials MDGL
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators MDGL
For 52 weeks
168.25 USD
368.29 USD
50 Day MA
279.88 USD
Shares Short Prior Month
4 434 650
200 Day MA
255.71 USD
Short Ratio
6.80
Shares Short
4 281 332
Short Percent
28.17 %
BeatStart